TMEM14EP
Transmembrane protein 14EP
Also known as: TM14E_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for TMEM14EP in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
125 residues, UniProt reviewed canonical sequence.
>Q6UXP3|TMEM14EP
1 MQMDPGPQVP LYWLGFVYAA LAALGGISGY AKVGSVQSPS AGFFFSELAG LDASQPSRNP
61 KEHLSSPVYI WDLARYYANK ILTLWNIYAC GFSCRCLLIV SKLGSMYGEQ ILSVVAMSQL
121 GLMKNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM14EP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.51
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM14EP as an antibody target. Whether an autoantibody or antibody against TMEM14EP could matter depends on whether native TMEM14EP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM14EP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TMEM14EP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...